Medicine for increasing intra-abdominal pressure
A technology of intraperitoneal pressure and drugs, applied in the direction of drug combination, etc., can solve the problems of reducing intraperitoneal pressure without hydroxyethyl starch and hydroxyethyl starch, and achieve the effect of reducing the effect, good medicinal prospects, and strong pharmacological effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] This embodiment takes severe acute pancreatitis (SAP) as the research object, and the reason for selecting SAP patients as the implementation object is that the intra-abdominal pressure increase caused by SAP is more typical, and the pathophysiological process of its intra-abdominal pressure increase is different from other The pathophysiology of disease-induced elevated intra-abdominal pressure is similar.
[0045] Severe acute pancreatitis (SAP) can occur in the early stage of systemic inflammatory response syndrome (SIRS), leading to multiple organ dysfunction (MODS), and in severe cases, multiple organ failure (MOF). The prognosis of SAP is dire, and the literature reports a case fatality rate of 20-30%. If MODS is complicated, the case fatality rate is as high as 50%.
[0046] One of the early characteristic symptoms of SAP is high abdominal distension and significantly increased intra-abdominal pressure. In 2005, Waele et al. found that the incidence of increased...
PUM
| Property | Measurement | Unit |
|---|---|---|
| molecular weight | aaaaa | aaaaa |
| molecular weight | aaaaa | aaaaa |
| molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 